These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21991753)

  • 1. Evaluation of adherence to national guideline for clinical follow up of HIV infected children using the proxy hematological, biochemical and anthropometric indicators of care.
    Berhan Y
    Ethiop Med J; 2011 Jul; 49(3):199-209. PubMed ID: 21991753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in absolute CD4 count with antiretroviral treatment in resource limited setting: a retrospective cohort study in children in Ethiopia.
    Berhan Y
    Ethiop Med J; 2011 Oct; 49(4):289-98. PubMed ID: 23409394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of children on HAART at police referral hospital, Addis Ababa, Ethiopia.
    Memirie ST
    Ethiop Med J; 2009 Jan; 47(2):159-64. PubMed ID: 19743796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on weight and height with the use of HAART in HIV-infected children.
    Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
    Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART).
    Taye B; Shiferaw S; Enquselassie F
    Ethiop Med J; 2010 Jan; 48(1):1-10. PubMed ID: 20607992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection.
    Chantry CJ; Byrd RS; Englund JA; Baker CJ; McKinney RE;
    Pediatr Infect Dis J; 2003 Dec; 22(12):1033-9. PubMed ID: 14688560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of anti-retroviral treatment in HIV-infected orphans and non-orphans at an ART centre in North India.
    Bhattacharya M; Saxena R
    Paediatr Int Child Health; 2012; 32(4):228-32. PubMed ID: 23164297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
    Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
    Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
    Ebissa G; Deyessa N; Biadgilign S
    AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
    Okechukwu AA; Okechukwu OI
    Niger J Clin Pract; 2011; 14(2):206-11. PubMed ID: 21860141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi.
    Bong CN; Yu JK; Chiang HC; Huang WL; Hsieh TC; Schouten EJ; Makombe SD; Kamoto K; Harries AD
    AIDS; 2007 Aug; 21(13):1805-10. PubMed ID: 17690580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).
    Dollfus C; Le Chenadec J; Faye A; Blanche S; Briand N; Rouzioux C; Warszawski J
    Clin Infect Dis; 2010 Jul; 51(2):214-24. PubMed ID: 20536367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hematological abnormalities and malnutrition in HIV-infected under five children in Enugu.
    Ezeonwu BU; Ikefuna AN; Oguonu T; Okafor HU
    Niger J Clin Pract; 2014; 17(3):303-8. PubMed ID: 24714007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin disorders affecting human immunodeficiency virus-infected children living in an orphanage in Ethiopia.
    Doni SN; Mitchell AL; Bogale Y; Walker SL
    Clin Exp Dermatol; 2012 Jan; 37(1):15-9. PubMed ID: 22182432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
    Luder E; Godfrey E; Godbold J; Simpson DM
    J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
    Shah I; Parikh S
    J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective evaluation of pretreatment and follow-up monitoring of HIV-infected adult patients in a resource-poor setting.
    Fawibe AE; Olafimihan KO; Salami AK; Desalu OO; Odeigah LO
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):289-91. PubMed ID: 20679511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.